Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorFernández-Cooke, Elisa
dc.contributor.authorGrasa, Carlos D.
dc.contributor.authorDomínguez-Rodríguez, Sara
dc.contributor.authorBarrios Tascón, Ana
dc.contributor.authorGiralt García, Gemma
dc.contributor.authorAnton, Jordi
dc.contributor.authorSánchez-Manubens, Judith
dc.date.accessioned2021-07-06T12:36:45Z
dc.date.available2021-07-06T12:36:45Z
dc.date.issued2021-01-18
dc.identifier.citationFernández-Cooke E, Grasa CD, Domínguez-Rodríguez S, Barrios Tascón A, Sánchez-Manubens J, Anton J, et al. Prevalence and Clinical Characteristics of SARS-CoV-2 Confirmed and Negative Kawasaki Disease Patients During the Pandemic in Spain. Front Pediatr. 2021 Jan 18;8:617039.
dc.identifier.issn2296-2360
dc.identifier.urihttps://hdl.handle.net/11351/6127
dc.descriptionCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Malaltia de Kawasaki (KD); Nens
dc.description.sponsorshipCG is funded by the Spanish Ministry of Science and Innovation—Instituto de Salud Carlos III and Fondos FEDER (Contrato Río Hortega CM19/00015).
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.ispartofseriesFrontiers in Pediatrics;8
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectCOVID-19 (Malaltia) - Complicacions
dc.subjectLimfadenitis
dc.subjectInfants
dc.subject.meshMucocutaneous Lymph Node Syndrome
dc.subject.meshSystemic Inflammatory Response Syndrome
dc.subject.meshCoronavirus Infections
dc.subject.mesh/complications
dc.titlePrevalence and Clinical Characteristics of SARS-CoV-2 Confirmed and Negative Kawasaki Disease Patients During the Pandemic in Spain
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3389/fped.2020.617039
dc.subject.decssíndrome mucocutáneo linfonodular
dc.subject.decssíndrome de respuesta inflamatoria sistémica
dc.subject.decsinfecciones por Coronavirus
dc.subject.decs/complicaciones
dc.relation.publishversionhttps://www.frontiersin.org/articles/10.3389/fped.2020.617039/full
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Fernández-Cooke E] Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario 12 de Octubre, Madrid, Spain. Pediatric Research and Clinical Trials Unit (UPIC), Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain. [Grasa CD] Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario La Paz, Madrid, Spain. [Domínguez-Rodríguez S] Pediatric Research and Clinical Trials Unit (UPIC), Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain. [Barrios Tascón A] Department of Pediatrics, Hospital Universitario Infanta Sofia, Madrid, Spain. [Sánchez-Manubens J, Anton J] Pediatric Rheumatology Department, Hospital Sant Joan de Déu, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Giralt G] Servei de Cardiologia Pediàtrica, Servei de Pediatria, Vall d'Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid33537269
dc.identifier.wos000613446700001
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2017-2020/CM19%2F00015
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple